These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 25543122

  • 1. SATB1 and 2 in colorectal cancer.
    Brocato J, Costa M.
    Carcinogenesis; 2015 Feb; 36(2):186-91. PubMed ID: 25543122
    [Abstract] [Full Text] [Related]

  • 2. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
    Mansour MA, Hyodo T, Akter KA, Kokuryo T, Uehara K, Nagino M, Senga T.
    Oncotarget; 2016 Jan 26; 7(4):4993-5006. PubMed ID: 26701851
    [Abstract] [Full Text] [Related]

  • 3. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
    Zhang Y, Tian X, Ji H, Guan X, Xu W, Dong B, Zhao M, Wei M, Ye C, Sun Y, Yuan X, Yang C, Hao C.
    PLoS One; 2014 Jan 26; 9(6):e100413. PubMed ID: 24971456
    [Abstract] [Full Text] [Related]

  • 4. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
    Nodin B, Johannesson H, Wangefjord S, O'Connor DP, Lindquist KE, Uhlén M, Jirström K, Eberhard J.
    Diagn Pathol; 2012 Aug 30; 7():115. PubMed ID: 22935204
    [Abstract] [Full Text] [Related]

  • 5. Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2.
    Yang MH, Yu J, Chen N, Wang XY, Liu XY, Wang S, Ding YQ.
    PLoS One; 2013 Aug 30; 8(12):e85353. PubMed ID: 24386467
    [Abstract] [Full Text] [Related]

  • 6. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
    Baba H, Ishikawa T, Mogushi K, Ishiguro M, Uetake H, Tanaka H, Sugihara K.
    Anticancer Res; 2016 Aug 30; 36(8):4069-76. PubMed ID: 27466515
    [Abstract] [Full Text] [Related]

  • 7. miR‑3666 suppresses cellular proliferation and invasion in colorectal cancer by targeting SATB2.
    Yang D, Li R, Xia J, Li W, Zhou H.
    Mol Med Rep; 2018 Dec 30; 18(6):4847-4854. PubMed ID: 30320357
    [Abstract] [Full Text] [Related]

  • 8. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.
    Luo LJ, Yang F, Ding JJ, Yan DL, Wang DD, Yang SJ, Ding L, Li J, Chen D, Ma R, Wu JZ, Tang JH.
    Gene; 2016 Dec 05; 594(1):47-58. PubMed ID: 27593563
    [Abstract] [Full Text] [Related]

  • 9. Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues.
    Kowalczyk AE, Godlewski J, Krazinski BE, Kiewisz J, Sliwinska-Jewsiewicka A, Kwiatkowski P, Pula B, Dziegiel P, Janiszewski J, Wierzbicki PM, Kmiec Z.
    Tumour Biol; 2015 Jun 05; 36(6):4441-52. PubMed ID: 25874491
    [Abstract] [Full Text] [Related]

  • 10. Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
    Li Y, Liu YH, Hu YY, Chen L, Li JM.
    World J Gastroenterol; 2016 Oct 14; 22(38):8528-8539. PubMed ID: 27784965
    [Abstract] [Full Text] [Related]

  • 11. SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer.
    Gu J, Wang G, Liu H, Xiong C.
    Cell Prolif; 2018 Aug 14; 51(4):e12455. PubMed ID: 29701273
    [Abstract] [Full Text] [Related]

  • 12. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
    Mansour MA, Hyodo T, Ito S, Kurita K, Kokuryo T, Uehara K, Nagino M, Takahashi M, Hamaguchi M, Senga T.
    FEBS J; 2015 Apr 14; 282(8):1394-405. PubMed ID: 25662172
    [Abstract] [Full Text] [Related]

  • 13. Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue-specific manner and demonstrates cell-type-dependent expression in the developing mouse CNS.
    Britanova O, Akopov S, Lukyanov S, Gruss P, Tarabykin V.
    Eur J Neurosci; 2005 Feb 14; 21(3):658-68. PubMed ID: 15733084
    [Abstract] [Full Text] [Related]

  • 14. miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
    Jiang G, Cui Y, Yu X, Wu Z, Ding G, Cao L.
    Oncotarget; 2015 Apr 20; 6(11):9457-66. PubMed ID: 25888635
    [Abstract] [Full Text] [Related]

  • 15. The role of SATB2 in skeletogenesis and human disease.
    Zhao X, Qu Z, Tickner J, Xu J, Dai K, Zhang X.
    Cytokine Growth Factor Rev; 2014 Feb 20; 25(1):35-44. PubMed ID: 24411565
    [Abstract] [Full Text] [Related]

  • 16. SATB1 expression is correlated with β-catenin associated epithelial-mesenchymal transition in colorectal cancer.
    Lv JH, Wang F, Shen MH, Wang X, Zhou XJ.
    Cancer Biol Ther; 2016 Feb 20; 17(3):254-61. PubMed ID: 26810818
    [Abstract] [Full Text] [Related]

  • 17. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.
    Magnusson K, de Wit M, Brennan DJ, Johnson LB, McGee SF, Lundberg E, Naicker K, Klinger R, Kampf C, Asplund A, Wester K, Gry M, Bjartell A, Gallagher WM, Rexhepaj E, Kilpinen S, Kallioniemi OP, Belt E, Goos J, Meijer G, Birgisson H, Glimelius B, Borrebaeck CA, Navani S, Uhlén M, O'Connor DP, Jirström K, Pontén F.
    Am J Surg Pathol; 2011 Jul 20; 35(7):937-48. PubMed ID: 21677534
    [Abstract] [Full Text] [Related]

  • 18. Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.
    Elebro J, Heby M, Gaber A, Nodin B, Jonsson L, Fristedt R, Uhlén M, Jirström K, Eberhard J.
    J Transl Med; 2014 Oct 17; 12():289. PubMed ID: 25323550
    [Abstract] [Full Text] [Related]

  • 19. Loss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer.
    Al-Sohaily S, Henderson C, Selinger C, Pangon L, Segelov E, Kohonen-Corish MR, Warusavitarne J.
    Histopathology; 2014 Aug 17; 65(2):155-63. PubMed ID: 24118100
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.